The regulatory path forward for CBD 13. June 2019/in News /by Stefan WeberWhile not everyone was on the same page about the legal path forward for hemp-derived CBD during Friday’s marathon FDA hearing, multiple speakers made clear that the current situation is untenable, with one predicting a wave of lawsuits, and others demanding that the agency either crack down on companies marketing such products, or explicitly spell out that existing regulatory frameworks can accommodate them. https://www.cannatic.de/wp-content/uploads/2019/06/Cannabis.png 1280 1244 Stefan Weber https://www.cannatic.de/wp-content/uploads/2019/02/cannatic-logo-green-257x40.png Stefan Weber2019-06-13 17:22:212019-06-13 17:22:21The regulatory path forward for CBD
The U.S.-Canada war for marijuana talents The U.S.-Canada war for marijuana talents